PCI The Journeys Within

Current Edition

Frankfurt 2027 – 12/10/26
ramusmedical
Regional News

Novo Nordisk’s Wegovy passes NICE checkpoint on course to blockbusterland

Novo Nordisk’s new weight loss contender Wegovy passed another milestone on the road to blockbusterland, courtesy of a green light from England’s drug cost watchdog. ...
Continue Reading →
Regional News

How United Cargo is Connecting Lifesaving Pharma to Patients Across the Globe

Airfreight is proven to be the quickest way of transporting goods long distances – with speed and efficiency being the keys to success. With over one billion pounds o...
Continue Reading →
Regional News

As Pfizer reaps megablockbuster COVID-19 sales, CEO doesn’t see virus going away for ‘foreseeable future’

Among all biopharma companies, Pfizer has had the most successful response to COVID-19 by bringing to market a hugely lucrative vaccine and a new antiviral pill. Desp...
Continue Reading →
Regional News

Teva survey finds COVID has ‘widened the chasm’ on health disparities

By now, it’s no surprise that the global pandemic has worsened long-standing health inequities—and pharma has stepped up with a flood of initiatives to try to tackle ...
Continue Reading →
Regional News

Novavax finally submits its COVID-19 vaccine to the FDA. Is it too late?

It's finally here: After a series of delays in the lead-up to Novavax's COVID-19 vaccine filing with the FDA, the biotech has completed its emergency use authorizatio...
Continue Reading →
Regional News

CMS’ Biogen decision could spell problems for Lilly, Roche Alzheimer’s drugs, half of surveyed neurologists say

Neurologists in the U.S. are agreeing with a new draft decision from the Centers for Medicare & Medicaid Services (CMS) that restricts reimbursement of Biogen’s c...
Continue Reading →
Regional News

GlaxoSmithKline’s HIV drug Cabenuva scores FDA nod for 2-month dosing

Last January, when GlaxoSmithKline’s ViiV Healthcare won a long-awaited approval for its long-acting HIV treatment Cabenuva, it was hailed as a game-changer as it rem...
Continue Reading →
Regional News

Novartis’ Sandoz reportedly the target of $25B buyout bid from Carlyle and Blackstone

As Novartis reviews its generics business, the list of potential Sandoz suitors has grown. The deal could become one of the biggest generic industry acquisitions ever...
Continue Reading →
Regional News

Biogen’s Aduhelm call to action backfires as CMS receives many more comments in favor of restrictive coverage: analyst

During a January Q&A call with investors, Biogen chief Michel Vounatsos pressed Aduhelm supporters to fight the Centers for Medicare & Medicaid Services’ (CMS...
Continue Reading →
Regional News

Novartis, Amgen settle their dueling lawsuits over migraine drug Aimovig

Novartis and Amgen have spent years arm wrestling one another over their development and commercialization deal on migraine prevention drug Aimovig. Now, the parties ...
Continue Reading →
Quotient